Where is Promethera headquartered?

Promethera is located in Mont-Saint-Guibert, walloon brabant.

Who invested in Promethera?

Promethera has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Promethera?

Promethera closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

promethera.com

Promethera

Promethera is a biopharmaceutical company that develops and commercializes novel cell-based therapies for the treatment of chronic liver diseases.

Business Model:

Revenue: $11M

Employees: 51-200

Geographic Data

Address: Rue Granbonpre, 11

City: Mont-Saint-Guibert

State: walloon brabant

Zip: B-1435

Country: BE

Financial Info

Stage:

series d

Raised Last:

$8M

Raised Total:

$145M

Social

Facebook

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Promethera is a biopharmaceutical company that develops and commercializes novel cell-based therapies for the treatment of chronic liver diseases.

Contact Phone:
+13210394300

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2016	Series C	7	$10.9M	Boehringer Ingelheim Venture Fund Fund+ Mitsubishi UFJ Capital Mitsui Global Investment S.R.I.W. SMS Investments Vesalius Biocapital Partners Boehringer Ingelheim Venture Fund Fund+ Mitsubishi UFJ Capital Mitsui Global Investment S.R.I.W. SMS Investments Vesalius Biocapital Partners
3/2012	Series B		$0	Shire Mitsui Global Investment Boehringer Ingelheim Venture Fund Shire Mitsui Global Investment Boehringer Ingelheim Venture Fund
11/2014	Series C		$0	Boehringer Ingelheim Shire SFPI-FPIM Boehringer Ingelheim Shire SFPI-FPIM
10/2016	Series C		$11M	Vesalius Biocapital SRIW Fund+ Boehringer Ingelheim Venture Fund
2/2010	Series A	4	$7.3M	Vesalius Biocapital Partners S.R.I.W. Limburgse Reconversie Maatschappij EQT life science
11/2014	Series C		$31.4M	Vesalius Biocapital Boehringer Ingelheim Venture Fund Shire Mitsui Global Investment SFPI-FPIM SMS Investments
5/2019	Series D		$44.4M	Itochu Corp Shinsei Capital Partners Medipal Holdings Corp Mirae Asset Capital Korea Investment Partners Mitsui & Co. Global Investment Ltd
6/2019	Series D	2	$48.1M	ITOCHU Technology Ventures Sansei Capital Investment ITOCHU Technology Ventures Sansei Capital Investment
4/2018	Debt		$11.4M
12/2019	Series D		$8.3M	Sony Innovation Fund Pegasus Tech Ventures Medipal Holdings Corporation
4/2018	Convertible Note	2	$11.5M	Shibuya Kogyo Shinsei Corporate Investment Shibuya Kogyo Shinsei Corporate Investment
12/2019	Series D	2	$8.4M	Pegasus Tech Ventures Sony Innovation Fund Pegasus Tech Ventures Sony Innovation Fund
12/2019	Series D	2	$8.4M	Pegasus Tech Ventures Sony Innovation Fund Pegasus Tech Ventures Sony Innovation Fund
4/2018	Convertible Note	2	$11.5M	Shibuya Kogyo Shinsei Corporate Investment Shibuya Kogyo Shinsei Corporate Investment
10/2016	Series C	7	$10.9M	Boehringer Ingelheim Venture Fund Fund+ Mitsubishi UFJ Capital Mitsui Global Investment S.R.I.W. SMS Investments Vesalius Biocapital Partners Boehringer Ingelheim Venture Fund Fund+ Mitsubishi UFJ Capital Mitsui Global Investment S.R.I.W. SMS Investments Vesalius Biocapital Partners
11/2014	Series C	3	$31.6M
3/2012	Series B	3	$31.4M

Acquisitions

Announced Date	Name	Price
4/2018	Baliopharm

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details